Chaperonin 10 immunosuppression
US7618935B2 · kind B2 · utility
5Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2003 |
| Grant date | Nov 17, 2009 |
| Priority date | — |
| Expiry date | Oct 22, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to the use of cpnl0 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.